{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:18:57Z","timestamp":1792192737443,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1053\/j.ackd.2011.01.009","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T16:34:24Z","timestamp":1304267664000},"page":"172-179","source":"Crossref","is-referenced-by-count":18,"title":["Have Advances in Extracorporeal Removal Techniques Changed the Indications for Their Use in Poisonings?"],"prefix":"10.1053","volume":"18","author":[{"given":"Fiona M.","family":"Garlich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2011.01.009_bib1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ki.2008.462","article-title":"Use of hemodialysis and hemoperfusion in poisoned patients","volume":"74","author":"Holubek","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2011.01.009_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/0885066609359592","article-title":"Extracorporeal removal techniques for the poisoned patient: a review for the intensivist","volume":"25","author":"Fertel","year":"2010","journal-title":"J Intensive Care Med"},{"issue":"suppl 1","key":"10.1053\/j.ackd.2011.01.009_bib3","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2215\/CJN.04000609","article-title":"Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes?","volume":"4","author":"Lameire","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1053\/ajkd.2000.16207","article-title":"Effectiveness of hemodialysis in the extracorporeal therapy of phenobarbital overdose","volume":"36","author":"Palmer","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2011.01.009_bib5","first-page":"1","article-title":"High-efficiency and high-flux hemodialysis","volume":"3","author":"Ambalavanan","year":"1999"},{"key":"10.1053\/j.ackd.2011.01.009_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/039139880202500516","article-title":"Dialysis membranes today","volume":"25","author":"Bowry","year":"2002","journal-title":"Int J Artif Organs"},{"key":"10.1053\/j.ackd.2011.01.009_bib7","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1097\/01.ASN.0000096373.13406.94","article-title":"Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study","volume":"14","author":"Cheung","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0272-6386(87)80155-5","article-title":"Acetate dialysate versus bicarbonate dialysate: a continuing controversy","volume":"9","author":"Diamond","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2011.01.009_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.ajkd.2009.01.265","article-title":"Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial","volume":"53","author":"Luo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2011.01.009_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-139X.2009.00665.x","article-title":"Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence","volume":"22","author":"Thomas","year":"2009","journal-title":"Semin Dial"},{"key":"10.1053\/j.ackd.2011.01.009_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/1556350500395040","article-title":"Successful treatment of acute phenobarbital intoxication by hemodiafiltration","volume":"44","author":"van de","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.ackd.2011.01.009_bib12","doi-asserted-by":"crossref","first-page":"c1","DOI":"10.1159\/000286343","article-title":"Continuous renal replacement therapy does not have a clear role in the treatment of poisoning","volume":"115","author":"Kim","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ackd.2011.01.009_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2006.04.080","article-title":"The availability and use of charcoal hemoperfusion in the treatment of poisoned patients","volume":"48","author":"Shalkham","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2011.01.009_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0735-6757(99)90254-1","article-title":"1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System","volume":"17","author":"Litovitz","year":"1999","journal-title":"Am J Emerg Med"},{"key":"10.1053\/j.ackd.2011.01.009_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/15563650701754763","article-title":"2006 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS)","volume":"45","author":"Bronstein","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.ackd.2011.01.009_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1081\/CLT-100100938","article-title":"High-efficiency dialysis for carbamazepine overdose","volume":"38","author":"Schuerer","year":"2000","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1053\/j.ackd.2011.01.009_bib17","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5414\/CNP57484","article-title":"High-flux hemodialysis\u2013an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication","volume":"57","author":"Kielstein","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00467-002-0841-2","article-title":"Extracorporeal removal of toxic valproic acid levels in children","volume":"17","author":"Dharnidharka","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1345\/aph.19387","article-title":"High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose","volume":"34","author":"Kane","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ackd.2011.01.009_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0272-6386(99)70235-0","article-title":"Successful treatment of valproic acid overdose with hemodialysis","volume":"33","author":"Johnson","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2011.01.009_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/ki.2008.443","article-title":"The underutilization of hemodialysis in patients with salicylate poisoning","volume":"75","author":"Fertel","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2011.01.009_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s004670100016","article-title":"Hemodiafiltration for vancomycin overdose in a\u00a0patient with end-stage renal failure","volume":"16","author":"Akil","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-2004-835959","article-title":"Large vancomycin overdose in two premature infants with minimal toxicity","volume":"21","author":"Miner","year":"2004","journal-title":"Am J Perinatol"},{"key":"10.1053\/j.ackd.2011.01.009_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s004670050633","article-title":"Hemodiafiltration for vancomycin overdose in a neonate with end-stage renal failure","volume":"13","author":"Goebel","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jac\/15.6.773","article-title":"Vancomycin toxicity: a prospective study","volume":"15","author":"Mellor","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.ackd.2011.01.009_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/jac\/25.4.679","article-title":"Nephrotoxicity of vancomycin, alone and with an aminoglycoside","volume":"25","author":"Rybak","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.ackd.2011.01.009_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s004670050697","article-title":"Treatment of vancomycin overdose using high-efficiency dialysis membranes","volume":"13","author":"Bunchman","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/AAC.36.7.1424","article-title":"Removal of vancomycin by high-flux hemodialysis membranes","volume":"36","author":"Quale","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.ackd.2011.01.009_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004670050405","article-title":"Charcoal hemoperfusion in a child with vancomycin overdose and chronic renal failure","volume":"12","author":"Panzarino","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib30","series-title":"Goldfrank\u2019s Toxicologic Emergencies","first-page":"698","article-title":"Anticonvulsants","author":"Doyon","year":"2011"},{"key":"10.1053\/j.ackd.2011.01.009_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0196-0644(95)70176-1","article-title":"Cardiovascular effects of carbamazepine toxicity","volume":"25","author":"Apfelbaum","year":"1995","journal-title":"Ann Emerg Med"},{"key":"10.1053\/j.ackd.2011.01.009_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/15563659309000412","article-title":"Clinical features in 28 consecutive cases of laboratory confirmed massive poisoning with carbamazepine alone","volume":"31","author":"Hojer","year":"1993","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1053\/j.ackd.2011.01.009_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1081\/CLT-120015836","article-title":"Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide","volume":"40","author":"Winnicka","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1053\/j.ackd.2011.01.009_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajem.2005.12.025","article-title":"Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning","volume":"24","author":"Brahmi","year":"2006","journal-title":"Am J Emerg Med"},{"key":"10.1053\/j.ackd.2011.01.009_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00006565-200112000-00015","article-title":"Management of carbamazepine overdose","volume":"17","author":"Spiller","year":"2001","journal-title":"Pediatr Emerg Care"},{"key":"10.1053\/j.ackd.2011.01.009_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cpt1975174433","article-title":"Plasma protein binding of carbamazepine","volume":"17","author":"Hooper","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.ackd.2011.01.009_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007691-198609000-00011","article-title":"Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose","volume":"8","author":"Vree","year":"1986","journal-title":"Ther Drug Monit"},{"key":"10.1053\/j.ackd.2011.01.009_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1053\/j.ackd.2011.01.009_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5414\/CNP59056","article-title":"Hemodialysis versus continuous veno-venous hemodiafiltration in the management of severe valproate overdose","volume":"59","author":"Kay","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1525-139X.2005.18106.x","article-title":"Extracorporeal management of valproic acid toxicity: a case report and review of the literature","volume":"18","author":"Al","year":"2005","journal-title":"Semin Dial"},{"key":"10.1053\/j.ackd.2011.01.009_bib41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00467-002-0946-7","article-title":"Effective removal of methotrexate by high-flux hemodialysis","volume":"17","author":"Saland","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib42","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0272-6386(96)90384-4","article-title":"Effective clearance of methotrexate using high-flux hemodialysis membranes","volume":"28","author":"Wall","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ackd.2011.01.009_bib43","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.20255","article-title":"High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma","volume":"100","author":"Widemann","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.ackd.2011.01.009_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00280-008-0772-0","article-title":"Renal dysfunction during and after high-dose methotrexate","volume":"63","author":"Green","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.ackd.2011.01.009_bib45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1592\/phco.30.1.111","article-title":"Treatment of methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase","volume":"30","author":"Vilay","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1053\/j.ackd.2011.01.009_bib46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI112088","article-title":"Polyglutamation of methotrexate. Is methotrexate a prodrug?","volume":"76","author":"Chabner","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ackd.2011.01.009_bib47","series-title":"Goldfrank\u2019s Toxicologic Emergencies","first-page":"778","article-title":"Antineoplastics: methotrexate","author":"Wang","year":"2011"},{"key":"10.1053\/j.ackd.2011.01.009_bib48","unstructured":"Bunchman TE, Ferris ME. Management of toxic ingestions with the use of renal replacement therapy. Pediatr Nephrol. In press."},{"key":"10.1053\/j.ackd.2011.01.009_bib49","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0014-2964(78)90010-5","article-title":"Hemodialysis and enzymatic cleavage of methotrexate in man","volume":"14","author":"Howell","year":"1978","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.ackd.2011.01.009_bib50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0196-0644(05)80210-0","article-title":"Intentional massive insulin overdose: recognition and management","volume":"22","author":"Roberge","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1053\/j.ackd.2011.01.009_bib51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5414\/CNP69354","article-title":"The influence of hemodialysis membranes on the plasma insulin level of diabetic patients on maintenance hemodialysis","volume":"69","author":"Abe","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1744-9987.2007.00491.x","article-title":"Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose","volume":"11","author":"Abe","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.ackd.2011.01.009_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.fct.2004.09.002","article-title":"Increased plasma creatine kinase activities triggered by edible wild mushrooms","volume":"43","author":"Nieminen","year":"2005","journal-title":"Food Chem Toxicol"},{"key":"10.1053\/j.ackd.2011.01.009_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ki.1996.48","article-title":"Rhabdomyolysis and myohemoglobinuric acute renal failure","volume":"49","author":"Zager","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2011.01.009_bib55","first-page":"141","article-title":"The effect of renal failure and hemodialysis on serum and urine myoglobin","volume":"18","author":"Hart","year":"1982","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ackd.2011.01.009_bib56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/039139889802100406","article-title":"Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis","volume":"21","author":"Nicolau","year":"1998","journal-title":"Int J Artif Organs"},{"key":"10.1053\/j.ackd.2011.01.009_bib57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/cc3055","article-title":"Extracorporeal therapies in acute rhabdomyolysis and myoglobin clearance","volume":"9","author":"Ronco","year":"2005","journal-title":"Crit Care"},{"key":"10.1053\/j.ackd.2011.01.009_bib58","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc3034","article-title":"Myoglobin clearance by super high-flux hemofiltration in a case of severe rhabdomyolysis: a case report","volume":"9","author":"Naka","year":"2005","journal-title":"Crit Care"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559511000115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559511000115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T12:46:31Z","timestamp":1712407591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559511000115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1548559511000115"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2011.01.009","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}